Harsh Golwala, MD
Interventional Cardiology · Portland, ORNPI 1265743686
Payments from drug & device makers
Across 339 payments — averaging $3702.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$928K
- Boston Scientific$273K
- Edwards Lifesciences$27K
- Ancora Heart, Inc.$11K
- Shockwave Medical, Inc$7K
- Jenavalve Technology, Inc.$4K
- plus $4K from 4 others
Across 33 payments — averaging $1920.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$63K
What the payments were for
- Consulting fees$46,78244%
- Speaking & faculty fees$18,41617%
- Travel & lodging$25,66924%
- Food & beverage$14,42314%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 115 | $927,818 |
| Boston Scientific | 69 | $273,494 |
| Edwards Lifesciences | 97 | $26,923 |
| Ancora Heart, Inc. | 16 | $11,140 |
| Shockwave Medical, Inc | 7 | $7,369 |
| Jenavalve Technology, Inc. | 3 | $4,494 |
| Siemens Medical Solutions USA, Inc. | 10 | $2,050 |
| Abbott | 20 | $1,835 |
| Cardiac Dimensions, Inc. | 1 | $77 |
| Abiomed | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$15,497
- AccuCinch$11,101
- CoreValve Evolut$8,130
- GENERAL - THERAPIES$7,606
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$7,344
- Edwards SAPIEN 3 Transcatheter Heart Valve$4,922
- Mitra Clip system$1,244
- Watchman$845
- SAPIEN 3 Ultra RESILIA$606
- GENERAL VASCULAR ACCESS$403
- PASCAL$229
- VersaCross Access Solution$202
- ACUSON SC2000 Diagnostic Ultrasound System$150
- AVVIGO Guidance System$134
- Farapulse$124
- AMPLATZER TORQVUE 45 X 45$117
- Resolute$112
- SYMPLICITY G3$108
- APOLLOTM$108
- ONYX FRONTIER$106
How this compares
$1,255,214 in reported general payments places this provider in the 95th percentile of 68 interventional cardiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $10,988 |
| ClopidogrelClopidogrel Bisulfate | 131 | $1,518 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Portland
- Ethan KorngoldPortland$1.1M
- Jason WollmuthPortland$945K
- Brandon JonesPortland$739K
- Amish DesaiPortland$666K
- Robert HodsonPortland$482K
- Logan VincentPortland$106K
- Richard SohnPortland$101K
- Kathryn DawsonPortland$57K
- Amged AbdelazizPortland$38K
- Daniel FeldmanPortland$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.